ALKEM LABORATORIES
Back to Cashflow Statement
|
ALKEM LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-811 Cr | ₹-1,145 Cr | ₹-1,761 Cr | ₹380 Cr | ₹-272 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALKEM LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-811 Cr |
| Mar2024 | ₹-1,145 Cr |
| Mar2023 | ₹-1,761 Cr |
| Mar2022 | ₹380 Cr |
| Mar2021 | ₹-272 Cr |
How is Cash Flow from Financing Activities of ALKEM LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-811 Cr | Negative | |
| Mar2024 | ₹-1,145 Cr | Negative | |
| Mar2023 | ₹-1,761 Cr | Negative | |
| Mar2022 | ₹380 Cr | Positive | |
| Mar2021 | ₹-272 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹65,317.7 Cr | -2.8% | -1% | 22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.8% |
-1% |
22.1% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses